National Accounts Director

The National Accounts Director (NAD) will be a key commercial leader responsible for driving adoption, utilization, and enterprise engagement for Pathlight MRD, the company’s oncology minimal residual disease (MRD) testing platform. This role is critical as the company expands adoption across early-stage breast cancer and prepares for an upcoming colorectal cancer launch in Q1 2026.

The NAD will leverage deep relationships across the oncology ecosystem, drive strategic penetration of national oncology groups, and ensure Pathlight MRD becomes embedded within precision medicine workflows, clinical pathways, and practice-wide testing strategies.

Responsibilities:

National Account Strategy & Execution

• Develop and execute a national strategy to accelerate adoption of Pathlight MRD within leading oncology networks, academic cancer centers, IDNs, and strategic accounts.
• Prioritize high-value customers in both the early-stage breast cancer and CRC landscapes, ensuring readiness for multi-tumor adoption.
• Engage C-suite leaders, medical directors, precision medicine committees, and operational stakeholders to influence enterprise-level decision-making.

Relationship Development & Expansion

• Leverage established relationships in the oncology diagnostics and MRD testing space to drive rapid access and evaluation of Pathlight MRD.
• Penetrate new national oncology organizations through evidence-driven conversations, MRD landscape insights, and strategic alignment with clinical leadership.
• Act as the primary national relationship owner and key escalation point across top-tier accounts.

Precision Medicine & Clinical Integration

• Partner with Precision Medicine, Clinical, Sales, and Medical Affairs teams to ensure Pathlight MRD is effectively integrated into clinical workflows, tumor boards, and precision oncology programs.
• Influence clinical pathways, early detection protocols, and post-surgical surveillance strategies across oncology groups.
• Provide account insights to optimize messaging, evidence generation, and positioning within the competitive MRD marketplace.

Clinical Adoption & Utilization Growth

• Drive utilization growth by guiding accounts through initial evaluation, pilot programs, and full enterprise rollout of Pathlight MRD.
• Collaborate with internal teams to support education, sample logistics integration, operational readiness, and ongoing clinical support.
• Track utilization patterns, identify barriers, and implement targeted strategies to accelerate growth across early-stage breast and CRC.

Strategic Partnerships & Enterprise Agreements

• Lead partnership development including preferred network agreements, multi-site rollout strategies, and real-world evidence collaborations centered on MRD testing.
• Support enterprise contract discussions, ensuring alignment with operational and clinical implementation requirements.
• Develop long-term customer partnerships aimed at broad, multi-tumor adoption of Pathlight MRD across oncology networks.

Requirements:

• 10+ years of experience in oncology diagnostics, molecular testing, or precision medicine; MRD testing experience strongly preferred.
• Established relationships with national oncology groups, community oncology leaders, and academic cancer centers.
• Proven success driving enterprise adoption of innovative diagnostics or precision medicine tools.
• Deep understanding of MRD testing workflows, interpretation, clinical decision-making impact, and integration into practice operations.
• Strong cross-functional leadership with ability to influence senior clinical and administrative executives.
• Thrives in a fast-moving, early-stage commercial environment with evolving needs.

Competencies

• Executive presence with exceptional communication and relationship-building skills
• Strategic and analytical thinker with strong operational execution
• Ability to navigate complex oncology organizations and influence clinical pathway decisions
• Entrepreneurial mindset, high adaptability, and proactive problem-solving
• Strong knowledge of the competitive MRD market and evolving evidence landscape

• Competitive Compensation and company wide benefits plan

• Opportunities for career advancement and professional development.

• A collaborative and innovative work environment dedicated to improving oncology outcomes.

SAGA Diagnostics is an equal opportunity employer, fully committed to achieving a diverse and inclusive workplace that embraces and encourages applicants of every background.  The company’s policy regarding equal employment opportunity means that all decisions regarding recruitment, hiring, benefits, wage and salary administration, scheduling, disciplinary action and termination will be made without unlawful discrimination on the basis of sex, gender, race, color, age, national origin, religion, disability, medical condition, genetic information, marital status, sexual orientation, gender identity or expression, citizenship status, pregnancy or maternity, veteran status, or any other status protected by applicable federal, state or local law. If you require reasonable accommodation in completing an application, interviewing, or otherwise participating in the employee selection process, please direct your inquiries to [email protected]. SAGA Diagnostics is a participant in the E-Verify program, learn more about the program and review our required disclosures here and here.